High Out-of-Pocket Costs Expected for Medicare Patients Taking Specialty Drugs in 2019
February 6th 2019Despite efforts to ease cost burden for Medicare Part D beneficiaries, high out-of-pocket costs for specialty tier drugs continue to be a concern for patients without low-income subsidies.
Read More